1. Home
  2. LSTR vs GRFS Comparison

LSTR vs GRFS Comparison

Compare LSTR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landstar System Inc.

LSTR

Landstar System Inc.

HOLD

Current Price

$166.26

Market Cap

5.7B

Sector

Industrials

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.55

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSTR
GRFS
Founded
1988
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.2B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
LSTR
GRFS
Price
$166.26
$7.55
Analyst Decision
Hold
Buy
Analyst Count
18
2
Target Price
★ $187.69
$10.87
AVG Volume (30 Days)
265.1K
★ 459.9K
Earning Date
10-27-2026
07-28-2022
Dividend Yield
1.04%
★ 1.42%
EPS Growth
N/A
★ N/A
EPS
★ 1.16
N/A
Revenue
★ $4,743,760,000.00
N/A
Revenue This Year
$17.36
$2.15
Revenue Next Year
$10.96
$6.22
P/E Ratio
$146.37
★ $18.67
Revenue Growth
N/A
★ N/A
52 Week Low
$121.12
$6.96
52 Week High
$228.46
$9.90

Technical Indicators

Market Signals
Indicator
LSTR
GRFS
Relative Strength Index (RSI) 41.74 53.23
Support Level $164.41 $7.33
Resistance Level $174.97 $7.68
Average True Range (ATR) 3.75 0.15
MACD 0.27 0.03
Stochastic Oscillator 29.05 67.50

Price Performance

Historical Comparison
LSTR
GRFS

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: